Financials Xiangyu Medical Co.,Ltd

Equities

688626

CNE100005394

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E. 06:00:00 2024-07-04 pm EDT 5-day change 1st Jan Change
30.48 CNY +1.16% Intraday chart for Xiangyu Medical Co.,Ltd -3.97% -42.80%

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 9,107 5,028 8,375 4,550 - -
Enterprise Value (EV) 1 9,107 5,028 8,375 4,550 4,550 4,550
P/E ratio 42.2 x 40.4 x 36.5 x 16.7 x 13.7 x 11.3 x
Yield 0.67% 0.75% 0.99% 2.12% 2.62% 2.92%
Capitalization / Revenue 17.4 x 10.3 x 11.2 x 5.04 x 4.12 x 3.41 x
EV / Revenue 17.4 x 10.3 x 11.2 x 5.04 x 4.12 x 3.41 x
EV / EBITDA - 32.8 x 31.8 x 14 x 11.5 x 9.42 x
EV / FCF - - - -23.6 x -54.2 x 14.8 x
FCF Yield - - - -4.24% -1.85% 6.75%
Price to Book 4.71 x 2.65 x 4.07 x 2.03 x 1.83 x 1.63 x
Nbr of stocks (in thousands) 160,000 157,726 157,153 157,109 - -
Reference price 2 56.92 31.88 53.29 28.96 28.96 28.96
Announcement Date 2/22/22 2/10/23 2/21/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 523.5 488.5 744.8 903.1 1,106 1,333
EBITDA 1 - - 153.2 263.5 325 394 483
EBIT 1 - 224.1 135.5 247.4 301.7 372 452.7
Operating Margin - 42.8% 27.73% 33.22% 33.4% 33.65% 33.96%
Earnings before Tax (EBT) 1 - 222.7 133 246.8 301 371.3 451.7
Net income 1 196.3 201.9 125.5 229.6 277.4 339.4 412.1
Net margin - 38.57% 25.68% 30.82% 30.71% 30.7% 30.92%
EPS 2 1.640 1.350 0.7900 1.460 1.733 2.120 2.573
Free Cash Flow 1 - - - - -193 -84 307
FCF margin - - - - -21.37% -7.6% 23.03%
FCF Conversion (EBITDA) - - - - - - 63.56%
FCF Conversion (Net income) - - - - - - 74.5%
Dividend per Share 2 - 0.3800 0.2400 0.5300 0.6150 0.7600 0.8450
Announcement Date 4/28/21 2/22/22 2/10/23 2/21/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1
Net sales 1 169.1
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 39.07
Net margin 23.11%
EPS -
Dividend per Share -
Announcement Date 4/17/24
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - - - -193 -84 307
ROE (net income / shareholders' equity) - 12.6% 6.53% 11.4% 12.1% 13.3% 14.7%
ROA (Net income/ Total Assets) - 12.7% 5.51% 9.23% 9.68% 10.4% 11.3%
Assets 1 - 1,586 2,275 2,488 2,865 3,272 3,640
Book Value Per Share 2 - 12.10 12.00 13.10 14.30 15.80 17.70
Cash Flow per Share 2 - 1.040 1.170 1.420 1.860 2.270 2.800
Capex 1 - 134 203 479 310 307 144
Capex / Sales - 25.57% 41.55% 64.33% 34.36% 27.8% 10.83%
Announcement Date 4/28/21 2/22/22 2/10/23 2/21/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
30.48 CNY
Average target price
48.78 CNY
Spread / Average Target
+60.04%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688626 Stock
  4. Financials Xiangyu Medical Co.,Ltd